EL

Emily Lilan Chen

Director Director DIN 08081058
DIN 08081058 First appointment Mar 2018 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2018
Shareholding value Locked Premium profile

About Emily Lilan Chen

Data last updated:

Emily Lilan Chen has 8 years in corporate governance. Formerly with 1 company, such as Mediquire India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08081058
Primary Designation Director
First Appointment 21 Mar 2018
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Mediquire India Private Limited U72900PN2017FTC172814
Director21 Mar 20182017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mediquire India Private Limited
Premium access

Shareholding and investment profile for Emily Lilan Chen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Emily Lilan Chen

Emily Lilan Chen has 8 years in corporate governance. Formerly with 1 company, such as Mediquire India Private Limited. Engaged in General Business. Contributes to corporate operations.

Emily Lilan Chen is associated with 0 companies as a director.

Emily Lilan Chen has expertise in General Business.

Emily Lilan Chen has 8 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available